A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts

BACKGROUND: Nuclear medicine is on the constant search of precision radiopharmaceutical approaches to improve patient management. Although discordant expression of the estrogen receptor (ER) and the human epidermal growth factor receptor 2 (HER2) in breast cancer is a known dilemma for appropriate p...

Descripción completa

Detalles Bibliográficos
Autores principales: Paquette, Michel, Phoenix, Serge, Lawson, Christine, Guérin, Brigitte, Lecomte, Roger, Tai, Lee-Hwa, Turcotte, Éric E., Leyton, Jeffrey V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334319/
https://www.ncbi.nlm.nih.gov/pubmed/32592121
http://dx.doi.org/10.1186/s13550-020-00656-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334319/
https://www.ncbi.nlm.nih.gov/pubmed/32592121
http://dx.doi.org/10.1186/s13550-020-00656-8

Ejemplares similares